Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.
|ClinicalTrials.gov Identifier: NCT01129713|
Recruitment Status : Unknown
Verified August 2014 by Effexus Pharmaceutical.
Recruitment status was: Recruiting
First Posted : May 25, 2010
Last Update Posted : August 5, 2014
|Condition or disease||Intervention/treatment||Phase|
|Gastroesophageal Reflux Disease (GERD) Heartburn Indigestion||Drug: Secretol Drug: Nexium||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in Gastroesophageal Reflux Disease(GERD)Patients With Severe Erosive Esophagitis(EE).|
|Study Start Date :||May 2010|
|Estimated Primary Completion Date :||May 2015|
|Estimated Study Completion Date :||May 2015|
Active Comparator: Nexium
Comparing 40 mg.once daily in healing erosive esophagitis.
Comparing 40 mg Nexium once daily to 80/80 Secretol once daily in healing erosive esophagitis.
Other Name: Esomeprazole
Active Comparator: Secretol
Comparing the efficacy of 80/80 Secretol once daily in healing erosive esophagitis.
Comparing 80/80 once daily to Nexium once daily in healing erosive esophagitis.
Other Name: lansoprazole/omeprazole combination
- Primary objective is to evaluate the relationship between healing and study drug allotment. [ Time Frame: 3 weeks of treatment ]The primary objective is to evaluate the relationship between healing and study drug allotment. The variables to be used are erosive esophagitis healing status after 3 weeks of treatment as assessed by EGD (upper endoscopy) comparing to base line EGD.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01129713
|Contact: Ronnie Fass, MD||520-792-1450 ext firstname.lastname@example.org|
|Contact: Marcia R. Willis, BS,CCRC||520-792-1450 ext email@example.com|
|United States, Arizona|
|Southern Arizona Veterans Health Care System||Recruiting|
|Tucson, Arizona, United States, 85723|
|Principal Investigator: Ronnie Fass, MD|
|Principal Investigator:||Ronnie Fass, MD||Southern Arizona VA Health Care System|